In addition, we show upregulation of Gal-9 expression and secretion by interferons, identify tumor-infiltrating immune cells that respond to Gal-9 blockade, and devise an effective combination therapy that boosts the antitumor effect of anti-Gal-9 therapy. Here, LGALS9 is linked to neoplasm.